FISPB
REGN icon

Fideuram - Intesa Sanpaolo Private Banking’s Regeneron Pharmaceuticals REGN Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10M Buy
16,049
+1,074
+7% +$731K 0.3% 94
2026
Q1 		$11.6M Sell
14,975
-8,072
-35% -$6.18M 0.41% 60
2025
Q4 		$17.8M Buy
+23,047
New +$15.7M 0.64% 35

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's REGN Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking increased its Regeneron Pharmaceuticals (REGN) stake by 7.2% in Q2 2026, buying an estimated $731K and bringing the position to 16,049 shares worth $10M. The position accounts for 0.3% of the portfolio, ranked #94.

Fideuram - Intesa Sanpaolo Private Banking first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $17.8M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Fideuram - Intesa Sanpaolo Private Banking held 16,049 shares of Regeneron Pharmaceuticals worth $10M as of Q2 2026.
  • Fideuram - Intesa Sanpaolo Private Banking bought 1,074 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $731K.
  • Regeneron Pharmaceuticals made up 0.3% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #94 holding.
  • Fideuram - Intesa Sanpaolo Private Banking first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Fideuram - Intesa Sanpaolo Private Banking's Regeneron Pharmaceuticals position peaked at $17.8M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.